论文信息 - A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911. - 字舞流文

A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911.

Y. Hosomi | S. Morita | K. Azuma | H. Kunitoh | M. Oba | T. Kato | Kazuhiko Yamada | H. Okamoto | Koshiro Watanabe | Y. Okuma | M. Nishikawa | H. Takeoka | Akira Sato | Y. Komase | Y. Nakahara | H. Aono